EN
HI

Sai Life Sciences Share price

SAILIFE

HealthcareLarge

756.95

40.30 (5.62%)
NSE
BSE
Last updated on 30 May, 2025 | 15:56 IST
BUYSELL
Today's High

784.40

Today's Low

711.95

52 Week Low

636.10

52 Week High

808.80

The current prices are delayed, login to your account for live prices

Sai Life Sciences Chart

Sai Life Sciences Share Key Metrics

Volume
36.96 L
Market Cap
15752.08 CR
LTQ@LTP
1@756.95
ATP
752.85
Var Margin
16.11 %
Circuit Range
573.35-859.95
Delivery %
56.27 %
Value
278.23 CR
ASM/GSM
No
Market Lot
1

Sai Life Sciences Futures & Options

Data Not Found

Sai Life Sciences Corporate Actions

DateAgenda
2025-05-13Audited Results
2025-02-06Quarterly Results
DateEvent TypeAgenda
2025-05-13Board MeetingAudited Results
2025-02-06Board MeetingQuarterly Results

Sai Life Sciences News

Sai Life Sciences shares jump 16% post listing. Should you buy, sell or hold?

Dec 18 2024 12:51:53

Sai Life Sciences shares to debut today. Check GMP and analyst predictions

Dec 18 2024 07:51:52
Read More

About Sai Life Sciences

NSE : 27839  
BSE : 544306  
ISIN : INE570L01029  

Our Company was originally incorporated as ‘Sai Dru Syn Laboratories Limited’ at Hyderabad Telangana (erstwhile Andhra Pradesh) as a public limited company under the Companies Act 1956 pursuant to a certificate of incorporation dated January 25 1999 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. Our Company received the certificate of commencement of business from Registrar of Companies Andhra Pradesh at Hyderabad on February 17 1999. Subsequently the name of our Company was changed from ‘Sai Dru Syn Laboratories Limited’ to ‘Sai Life Sciences Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on December 11 2003 and a fresh certificate of incorporation dated December 16 2003 consequent to change of name was issued by the Registrar of Companies Andhra Pradesh at Hyderabad. Thereafter the name of the Company was changed from ‘Sai Life Sciences Limited’ to ‘Sai Advantium Pharma Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on August 16 2006 and a fresh certificate of incorporation dated August 30 2006 consequent to change of name was issued by the Registrar of Companies Andhra Pradesh at Hyderabad. Subsequently the name of our Company was changed from ‘Sai Advantium Pharma Limited’ to its present name ‘Sai Life Sciences Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on April 20 2012 and a fresh certificate of incorporation dated May 28 2012 consequent to change of name was issued by the Registrar of Companies Andhra Pradesh at Hyderabad.Major Events and Milestones:1999- Incorporation of our Company2002- Inauguration of our R&D labs in ICICI Knowledge Park Hyderabad.2004- Strategic acquisitions of Prasad Drugs Limited the current Unit III Bolarum Facility2006- Investment by Advantium LLC in our Company to set-up discovery services to expand our Company’s business.- Acquired Merrifield Pharma Private Limited2007- Acquisition of shares of our Company held by Advantium LLC by Sequoia Capital India Investments III2008- Investment by MPM Investment Mauritius in our Company2014- Acquisition of shares of our Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 12016- Acquisition of shares of our Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of our Company2019- Opened biology facility in Watertown (Greater Boston MA) U.S.A2020- Launched Sai Nxt an initiative aiming to transform the organization into a new generation CDMO- Addition of cellular analysis platforms at our discovery biology facility in Cambridge Massachusetts USA2021- Opened new 75000 sq. ft. discovery biology facility at our integrated R&D campus at Unit II Hyderabad Facility2022- Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility- Announced the launch of BIOVIA Electronic Lab Notebook application2023- Inauguration of high potency API manufacturing block at Unit IV Bidar Facility.2024- Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad

Sai Life Sciences Management

NamePosition
Dr. Kanumuri Ranga Raju Chairman & Wholetime Director
Mr. Krishnam Raju Kanumuri Managing Director & CEO
Mr. Mitesh Daga Non Exe. & Nominee Director
Mr. Rajagopal Srirama Tatta Independent Director
Mr. Ramesh Ganesh Iyer Independent Director
Read More

Sai Life Sciences FAQs

The Buying Price of Sai Life Sciences share is 756.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sai Life Sciences share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Sai Life Sciences shares is 92.89. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sai Life Sciences shares is 7.43. Useful to assess the stock's value relative to its book value.

To assess Sai Life Sciences’s valuation compare Sector P/E, P/B which are 37.05 & 4.02 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sai Life Sciences is 15752.08 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sai Life Sciences share price is 808.80 & 636.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.